Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Alison Sathe
Anders Vinther
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Conference Spotlight

GMP Inspection Case Study Focuses on Inadequate Deviation Investigations

No items found.

How Can a Small Pharma Firm Begin Building a Robust QMS?

No items found.

On-Demand Webinar | Turning Failure into Success

No items found.
Conference Spotlight

Countrywide Import Alert Among Recent FDA Enforcement Activities

No items found.

The Current State of Smart Devices and Combination Products

No items found.

How to Prepare for an FDA Inspection: 4 Posts

No items found.
Conference Spotlight

Redica Systems Expert Jerry Chapman to Present at SQA Annual Meeting

No items found.
Conference Spotlight

Data Integrity Concerns Discovered in Gene Therapy Product Submissions

No items found.

How Can Medical Device Manufacturers Prepare for the EU MDR?

No items found.
Conference Spotlight

Facility Inspections Among FY2020 CVM Accomplishments

No items found.
Trends

Part II: An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report

No items found.

On-Demand Webinar | QMS for Small Pharma and Biotech Firms

No items found.
Trends

Part I: An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report

No items found.
Conference Spotlight

Update on US/EU MRA: Inspection Reports Being Exchanged

No items found.
Conference Spotlight

PIC/S GMP Inspection Reliance Guidance Helps Global Agencies During Pandemic

No items found.
Conference Spotlight

Redica Systems Senior GMP Quality Expert Jerry Chapman to Present at PDA Annual

No items found.

One Year Since COVID-19: A Roundup

No items found.
Conference Spotlight

Onsite Pharma FDA Inspections During COVID-19 Respect State Restrictions

No items found.